TW258736B - - Google Patents

Info

Publication number
TW258736B
TW258736B TW082110279A TW82110279A TW258736B TW 258736 B TW258736 B TW 258736B TW 082110279 A TW082110279 A TW 082110279A TW 82110279 A TW82110279 A TW 82110279A TW 258736 B TW258736 B TW 258736B
Authority
TW
Taiwan
Application number
TW082110279A
Other languages
Chinese (zh)
Inventor
Mattes Henri
Original Assignee
Samdoz Pharmaceutical Factory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samdoz Pharmaceutical Factory filed Critical Samdoz Pharmaceutical Factory
Application granted granted Critical
Publication of TW258736B publication Critical patent/TW258736B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/08Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
TW082110279A 1992-12-04 1993-12-06 TW258736B (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929225396A GB9225396D0 (en) 1992-12-04 1992-12-04 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
TW258736B true TW258736B (OSRAM) 1995-10-01

Family

ID=10726140

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082110279A TW258736B (OSRAM) 1992-12-04 1993-12-06

Country Status (18)

Country Link
EP (1) EP0606044A1 (OSRAM)
JP (1) JPH06228122A (OSRAM)
KR (1) KR940014377A (OSRAM)
CN (1) CN1095417A (OSRAM)
AU (1) AU5211293A (OSRAM)
CA (1) CA2110553A1 (OSRAM)
CZ (1) CZ261493A3 (OSRAM)
FI (1) FI935409L (OSRAM)
GB (1) GB9225396D0 (OSRAM)
HU (1) HUT65910A (OSRAM)
IL (1) IL107838A0 (OSRAM)
MX (1) MX9307608A (OSRAM)
NO (1) NO934372L (OSRAM)
NZ (1) NZ250344A (OSRAM)
PL (1) PL301281A1 (OSRAM)
SK (1) SK135493A3 (OSRAM)
TW (1) TW258736B (OSRAM)
ZA (1) ZA939088B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228328C2 (de) * 1992-08-26 1999-02-11 Agie Sa Maschine und Verfahren zum funkenerosiven Drahtschneiden mit einer im Querschnitt verformten Drahtelektrode
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
US5731343A (en) * 1995-02-24 1998-03-24 The Scripps Research Institute Method of use of radicicol for treatment of immunopathological disorders
WO1996033989A1 (fr) * 1995-04-26 1996-10-31 Kyowa Hakko Kogyo Co., Ltd. Derives de radicicol
WO2000038674A1 (en) * 1998-12-24 2000-07-06 Novation Pharmaceuticals Inc. COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
ATE328888T1 (de) 2000-08-25 2006-06-15 Sloan Kettering Inst Cancer Radicicol und monocillin und ihre analogen und ihre anwendungen
JP2004292315A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd Tak1阻害剤
JP2004292314A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd ケラチノサイト増殖抑制剤
GB0112522D0 (en) * 2001-05-23 2001-07-11 Ici Plc Catalytic process
US7915306B2 (en) 2002-03-08 2011-03-29 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
CN104876904A (zh) 2002-03-08 2015-09-02 卫材R&D管理株式会社 用作医药品的大环化合物
WO2003086334A1 (fr) * 2002-04-17 2003-10-23 Taisho Pharmaceutical Co., Ltd. Produit tonique pour la pousse de cheveux
US20060079494A1 (en) * 2004-09-27 2006-04-13 Santi Daniel V Specific kinase inhibitors
US7601852B2 (en) 2006-05-11 2009-10-13 Kosan Biosciences Incorporated Macrocyclic kinase inhibitors
US8609640B2 (en) 2007-07-25 2013-12-17 Eisai, Inc. Multikinase inhibitors for use in the treatment of cancer
EP2215471B1 (en) 2007-10-29 2012-02-08 Eisai R&D Management Co., Ltd. Methods for prognosing the ability of a zearalenone analog compound to treat cancer
CN101889005B (zh) 2007-12-07 2015-06-03 卫材R&D管理株式会社 玉米赤霉烯酮大环内酯类似物合成过程中的中间物
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196019A (en) * 1964-04-06 1965-07-20 Purdue Research Foundation Anabolic and estrogenic compound and process of making

Also Published As

Publication number Publication date
JPH06228122A (ja) 1994-08-16
ZA939088B (en) 1995-06-05
FI935409A7 (fi) 1994-06-05
CN1095417A (zh) 1994-11-23
FI935409A0 (fi) 1993-12-02
KR940014377A (ko) 1994-07-18
EP0606044A1 (en) 1994-07-13
SK135493A3 (en) 1994-08-10
CZ261493A3 (en) 1994-07-13
CA2110553A1 (en) 1994-06-05
NZ250344A (en) 1995-10-26
NO934372D0 (no) 1993-12-02
PL301281A1 (en) 1994-06-13
HUT65910A (en) 1994-07-28
GB9225396D0 (en) 1993-01-27
NO934372L (no) 1994-06-06
HU9303444D0 (en) 1994-04-28
AU5211293A (en) 1994-06-16
MX9307608A (es) 1995-01-31
FI935409L (fi) 1994-06-05
IL107838A0 (en) 1994-04-12

Similar Documents

Publication Publication Date Title
TW253079B (OSRAM)
DK0598561T3 (OSRAM)
DK0613608T3 (OSRAM)
DK0553875T3 (OSRAM)
DK0551248T3 (OSRAM)
DK0603481T3 (OSRAM)
TW239891B (OSRAM)
TW246756B (OSRAM)
TW258736B (OSRAM)
TW248568B (OSRAM)
DK0596750T3 (OSRAM)
DK0574087T3 (OSRAM)
DK0632741T3 (OSRAM)
BR9207065A (OSRAM)
TW257824B (OSRAM)
TW262547B (OSRAM)
FR2688751B1 (OSRAM)
DK0574276T3 (OSRAM)
DK0571874T3 (OSRAM)
DK0564197T3 (OSRAM)
DK0596569T3 (OSRAM)
DK0599441T3 (OSRAM)
TW222284B (OSRAM)
DK0559942T3 (OSRAM)
DE9209779U1 (OSRAM)